MAM
Meeder Asset Management Portfolio holdings
AUM
$1.63B
1-Year Return
27.94%
This Quarter Return
+5.92%
1 Year Return
+27.94%
3 Year Return
+116.82%
5 Year Return
+187.4%
10 Year Return
+462.19%
AUM
$1.18B
AUM Growth
+$259M
(+28%)
Cap. Flow
+$204M
Cap. Flow
% of AUM
17.31%
Top 10 Holdings %
Top 10 Hldgs %
25.61%
Holding
1,948
New
327
Increased
687
Reduced
553
Closed
263
Top Buys
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$52.5M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$48.5M |
| 3 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$44.6M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$18.7M |
| 5 |
Vanguard Total Bond Market
BND
|
+$14.9M |
Top Sells
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$5.65M |
| 2 |
Fidelity National Financial
FNF
|
+$4.63M |
| 3 |
S&P Global
SPGI
|
+$4.58M |
| 4 |
PPL Corp
PPL
|
+$4.41M |
| 5 |
Carnival Corp
CCL
|
+$3.85M |
Sector Composition
| 1 | Financials | 12.77% |
| 2 | Technology | 12.57% |
| 3 | Healthcare | 9.89% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Iovance Biotherapeutics
IOVA
$883M
| $9K | ﹤0.01% |
1,107
+871
| +369% | +$7.08K |
|
1152
Lipocine
LPCN
$16.2M
| $9K | ﹤0.01% |
148
+51
| +53% | +$3.1K |
|
1153
MiMedx Group
MDXG
$1.05B
| $9K | ﹤0.01% |
707
-936
| -57% | -$11.9K |
|
1154
Myers Industries
MYE
$612M
| $9K | ﹤0.01% |
452
+189
| +72% | +$3.76K |
|
1155
National CineMedia
NCMI
$442M
| $9K | ﹤0.01% |
134
-71
| -35% | -$4.77K |
|
1156
Onto Innovation
ONTO
$5.27B
| $9K | ﹤0.01% |
375
-78
| -17% | -$1.87K |
|
1157
Dave & Buster's
PLAY
$796M
| $9K | ﹤0.01% |
170
-309
| -65% | -$16.4K |
|
1158
Qualys
QLYS
$4.9B
| $9K | ﹤0.01% |
138
-301
| -69% | -$19.6K |
|
|
RGLS
1159
DELISTED
Regulus Therapeutics
RGLS
| $9K | ﹤0.01% |
75
+39
| +108% | +$4.68K |
|
1160
Regis Corp
RGS
$69M
| $9K | ﹤0.01% |
31
+9
| +41% | +$2.61K |
|
1161
Sterling Infrastructure
STRL
$9.6B
| $9K | ﹤0.01% |
563
+425
| +308% | +$6.79K |
|
1162
Tejon Ranch
TRC
$455M
| $9K | ﹤0.01% |
414
+105
| +34% | +$2.28K |
|
1163
Timberland Bancorp
TSBK
$283M
| $9K | ﹤0.01% |
332
+107
| +48% | +$2.9K |
|
1164
Travere Therapeutics
TVTX
$2.22B
| $9K | ﹤0.01% |
421
+296
| +237% | +$6.33K |
|
1165
Universal Logistics Holdings
ULH
$665M
| $9K | ﹤0.01% |
+370
| New | +$9K |
|
1166
Valhi
VHI
$475M
| $9K | ﹤0.01% |
113
-74
| -40% | -$5.89K |
|
|
EGRX
1167
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $9K | ﹤0.01% |
182
-660
| -78% | -$32.6K |
|
|
BFX
1168
DELISTED
BowFlex Inc.
BFX
| $9K | ﹤0.01% |
672
+617
| +1,122% | +$8.26K |
|
|
VRTV
1169
DELISTED
VERITIV CORPORATION
VRTV
| $9K | ﹤0.01% |
307
-51
| -14% | -$1.5K |
|
|
CDK
1170
DELISTED
CDK Global, Inc.
CDK
| $9K | ﹤0.01% |
125
-1,035
| -89% | -$74.5K |
|
|
FOE
1171
DELISTED
Ferro Corporation
FOE
| $9K | ﹤0.01% |
+373
| New | +$9K |
|
|
ZIXI
1172
DELISTED
Zix Corporation
ZIXI
| $9K | ﹤0.01% |
2,030
| – | – |
|
|
BOLD
1173
DELISTED
Audentes Therapeutics, Inc
BOLD
| $9K | ﹤0.01% |
289
+174
| +151% | +$5.42K |
|
|
CBM
1174
DELISTED
Cambrex Corporation
CBM
| $9K | ﹤0.01% |
178
+113
| +174% | +$5.71K |
|
|
FTD
1175
DELISTED
FTD Companies, Inc. Common Stock
FTD
| $9K | ﹤0.01% |
1,343
+850
| +172% | +$5.7K |
|